Turinabol vs. Oxandrolone: Mechanism of Action and Side Effects Compared

Turinabol and oxandrolone are two oral anabolic-androgenic steroids (AAS) that are frequently compared in gym circles. Both are controlled substances in the United States. Our editorial team compares their chemistry, their mechanisms and, above all, their documented risks, without providing any guidance on use, dosing or cycling.

What these two compounds are

Oxandrolone is a synthetic derivative of dihydrotestosterone, first developed in the early 1960s. Unlike most AAS, it has a recognized medical history: it was approved in the US to help patients regain weight after surgery, trauma, chronic infection or prolonged corticosteroid therapy, and it has been studied in burn recovery.

Turinabol, chemically chlorodehydromethyltestosterone, is a derivative of methandrostenolone with an added chlorine atom. It is best known historically as the drug at the center of the East German state-sponsored doping program of the 1970s and 1980s, where it was given to athletes, sometimes without their knowledge.

So the two differ even in their origins: oxandrolone has a legitimate, if narrow, medical role, while turinabol is essentially a doping agent with no current approved medical use in the United States.

Both are taken orally and both are chemically modified to survive passage through the liver, a modification that carries specific health consequences discussed later.

How anabolic steroids act

Anabolic steroids work by binding to the androgen receptor inside cells, the same receptor that natural testosterone uses. Once activated, the receptor influences gene expression in a way that promotes protein synthesis and muscle growth.

They also exert anti-catabolic effects, partly by interfering with the action of cortisol, a hormone that breaks down muscle. This combination of building more and breaking down less is what underlies their effect on muscle mass.

Beyond muscle, androgen receptors are present throughout the body, in the heart, liver, skin, brain and reproductive organs. This is why the effects of AAS are never confined to muscle and why the side-effect profile is so broad.

A critical point is that all synthetic androgens, to varying degrees, suppress the body's own hormone production through negative feedback. The brain senses high androgen levels and shuts down its signal to the testes, reducing natural testosterone and sperm production.

Chemical differences

Oxandrolone carries an oxygen atom in its A-ring that makes it unusual among steroids and contributes to its relatively mild androgenic character. It does not convert to estrogen, so estrogen-related effects such as breast tissue growth are not typical of it.

Turinabol's defining feature is a chlorine atom that blocks its conversion to estrogen and also prevents it from converting to more potent androgens. Like oxandrolone, it does not aromatize to estrogen.

Both are 17-alpha-alkylated, a chemical change that allows them to be taken by mouth without being destroyed immediately by the liver. This same modification is responsible for their potential to stress and damage the liver, a shared risk.

Documented side effects

Because both drugs are 17-alpha-alkylated orals, liver toxicity is a central concern. Reported problems range from elevated liver enzymes to cholestasis (impaired bile flow) and, in rare cases, peliosis hepatis, a condition of blood-filled cysts in the liver that can be life-threatening.

Both adversely affect cholesterol, typically lowering protective HDL and raising harmful LDL. Oxandrolone in particular has a marked effect on lipids despite its reputation as mild, and these changes contribute to long-term cardiovascular risk.

A useful reference here is farmacia deportiva en españa.

Both suppress natural testosterone production, which can cause testicular shrinkage, reduced fertility and, after stopping, a period of low testosterone with fatigue, low mood and loss of libido. In some users, recovery is slow or incomplete.

• Liver: enzyme elevation, cholestasis, rare serious liver injury.
• Heart: adverse cholesterol changes, raised cardiovascular risk.
• Hormones: suppressed natural testosterone, possible infertility.
• Women: risk of virilization, including voice deepening, which can be permanent.

For women, both drugs carry a risk of virilization: deepening of the voice, facial hair growth and other masculinizing changes, some of which do not reverse after stopping. Oxandrolone is sometimes described as milder, but milder is not the same as safe, and serious effects are still possible.

Legal and anti-doping status

In the United States, both oxandrolone and turinabol are Schedule III controlled substances under the Anabolic Steroid Control Act. Possessing them without a valid prescription is illegal, and oxandrolone can only be obtained legally for approved medical indications.

Both are prohibited at all times by the World Anti-Doping Agency. Turinabol is especially notable in anti-doping history because long-lasting metabolites allow it to be detected months after use, which led to many retrospective positive tests when testing methods improved.

Products sold on the black market are also frequently mislabeled or contaminated, meaning a person may not even receive the compound they believe they are taking. This adds unpredictable risk on top of the drugs' inherent dangers.

Because of all this, the honest editorial position is that non-medical use of either drug carries legal jeopardy, anti-doping consequences and genuine health risk, and that medical use of oxandrolone belongs strictly under a physician's supervision.

Conclusions of the editorial team

Turinabol and oxandrolone share a basic mechanism, acting on the androgen receptor, and a shared set of serious risks: liver stress, adverse cholesterol changes and suppression of natural hormones.

Their differences lie mainly in origin and history, oxandrolone retaining a narrow medical role, turinabol remaining a notorious doping agent, rather than in a meaningfully safer profile for either.

The evidence does not support a notion that one is a safe choice for non-medical use; both carry significant dangers and legal risk.

Readers wanting context may find our articles on how anabolic steroids affect the heart, on liver health and oral steroids, and on the history of doping in elite sport informative.

References

1. Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
2. Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502–521.
3. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem. 1997;43(7):1262–1279.
4. Sobolevsky T, Rodchenkov G. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine. J Steroid Biochem Mol Biol. 2012;128(3-5):121–127.
5. Orr R, Fiatarone Singh M. The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. Drugs. 2004;64(7):725–750.
6. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513–554.